|Bid||6.53 x 0|
|Ask||6.73 x 0|
|Day's range||5.73 - 5.73|
|52-week range||3.58 - 63.00|
|Beta (5Y monthly)||1.72|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
After losing some value lately, a hammer chart pattern has been formed for Cardlytics (CDLX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Cardlytics (CDLX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Shares of advertising-technology company Cardlytics (NASDAQ: CDLX) sank to an all-time low on Wednesday after the company announced disappointing financial results for the third quarter of 2022. As of 1:20 p.m. ET, Cardlytics stock was down 43% for the session and down 96% from the high it reached in early 2021. Cardlytics partners with financial institutions to track real consumer spending and offer advertising opportunities to marketers.